Target intelligence / Profile preview

Transition metal ions involved in Fenton chemistry

Molecular classification
Metal ions, Redox-active catalysts
01

Overview

Transition metal ions, primarily iron (Fe2+) and copper (Cu+), are the central catalysts in Fenton and Fenton-like chemistry, where they react with hydrogen peroxide to generate the highly reactive hydroxyl radical (.OH) (Winterbourn, 1995, Toxicology Letters). This process is a major source of oxidative stress within cells, as hydroxyl radicals cause non-specific damage to DNA, proteins, and membrane lipids through lipid peroxidation (Wardman & Candeias, 1996, Radiation Research). Under physiological conditions, these metals are sequestered by storage and transport proteins like ferritin and transferrin to prevent unwanted redox activity. However, in various disease states, the labile metal pool increases, leading to pathological oxidative damage and the induction of ferroptosis, a form of regulated cell death (Dixon & Stockwell, 2014, Nature Chemical Biology). Therapeutic targeting of these ions typically involves chelation therapy, using drugs like deferoxamine or deferiprone to sequester the metals and prevent their participation in radical-generating reactions (Kontoghiorghes et al., 2004, Current Medicinal Chemistry). This approach is vital in treating iron overload disorders, Wilson's disease, and is being investigated for neurodegenerative and cardiovascular conditions (Jomova & Valko, 2011, Toxicology).

Other names
Fenton-active metalsRedox-active metal ionsLabile iron poolLabile copper poolFenton reagentsChelatable metal ions
02

Mechanism of action

Chelation and sequestration of redox-active metal ions to prevent the formation of reactive oxygen species (ROS) via Fenton and Fenton-like reactions.

03

Biological functions

Redox signalingOxidative stress generationCatalysisInduction of ferroptosisLipid peroxidation
04

Disease associations

Neurodegenerative diseaseHemochromatosisWilson's diseaseCancerIschemia-reperfusion injuryCardiovascular diseaseThalassemia
05

Safety considerations

Systemic depletion of essential trace elementsNephrotoxicityOtotoxicityAgranulocytosisNeurotoxicity due to metal redistributionGastrointestinal irritation
06

Interacting drugs

Deferoxamine

7 more in the full profile.

07

Biomarkers

Serum ferritinTransferrin saturationLabile iron pool (LIP)Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)Non-transferrin bound iron (NTBI)

Beyond the preview

Go deeper on Transition metal ions involved in Fenton chemistry.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transition metal ions involved in Fenton chemistry.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call